Pasithea Therapeutics (Pasithea Therapeutics) Other Net Income (Loss) : $-0.18 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Pasithea Therapeutics Other Net Income (Loss)?

Pasithea Therapeutics's Other Net Income (Loss) for the three months ended in Mar. 2024 was $0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.18 Mil.

Pasithea Therapeutics's quarterly Other Net Income (Loss) declined from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($-0.02 Mil) but then increased from Dec. 2023 ($-0.02 Mil) to Mar. 2024 ($0.00 Mil).

Pasithea Therapeutics's annual Other Net Income (Loss) declined from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($-2.21 Mil) but then increased from Dec. 2022 ($-2.21 Mil) to Dec. 2023 ($-0.45 Mil).

Pasithea Therapeutics Other Net Income (Loss) Historical Data

The historical data trend for Pasithea Therapeutics's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pasithea Therapeutics Other Net Income (Loss) Chart

Pasithea Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

-2.21

-0.45

Pasithea Therapeutics Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial										-0.27	-0.17	-	-0.02	-

Pasithea Therapeutics Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.18 Mil.

Pasithea Therapeutics Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Pasithea Therapeutics's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Pasithea Therapeutics (Pasithea Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pasithea Therapeutics Corp (NAS:KTTAW) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

KTTA:USA

Address

1111 Lincoln Road, Suite 500, Miami Beach, FL, USA, 33139

Website

https://www.pasithea.com

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.